[Pleural-origin malignant lymphoma in an elderly patient with chronic empyema and infection with the Epstein-Barr virus]. 1997

Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
Department of Internal Medicine, Tachikawa Medical Center Omotemachi Hospital.

A 73-year-old woman with a long-standing history of right-sided chronic empyema complained of lumbago. An artificial pneumothorax had been induced to treat pulmonary tuberculosis about 40 years previously. The year after she began to complain of lumbago, a tumor mass over the right anterior chest wall had grown rapidly. Pathologic examination revealed that it was a malignant lymphoma (Non-Hodgkin's lymphoma, diffuse large cell, B cell type). Chemotherapy with cyclophosphamide, adriamycin, vincristine, and prednisolone, and then radiation therapy were given. The patient responded very well. The tumor mass on the surface of the chest wall disappeared completely. She was alive and well and there was no evidence of recurrence at the seven-month follow-up examination. Analysis with the polymerase chain reaction showed that the tumor contained DNA of the Epstein-Barr virus. The chronic empyema and local infection with the Epstein-Barr virus might have been a factor in the development of the malignant lymphoma.

UI MeSH Term Description Entries
D010997 Pleural Neoplasms Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms. Neoplasms, Pleural,Neoplasm, Pleural,Pleural Neoplasm
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection

Related Publications

Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
August 2004, International journal of hematology,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
November 1992, Lancet (London, England),
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
October 1986, Rinsho shinkeigaku = Clinical neurology,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
March 2000, Nihon rinsho. Japanese journal of clinical medicine,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
September 2013, Modern rheumatology,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
October 1993, The American journal of pathology,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
June 2014, Clinical and experimental dermatology,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
December 2014, Chinese journal of cancer,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
April 2000, Australian and New Zealand journal of medicine,
Y Mitsugi, and H Katsunuma, and T Asano, and K Ogawa, and H Sakurai, and Y Nishimura, and K Satoh, and K Shin, and M Takasaki
January 1987, Annual review of medicine,
Copied contents to your clipboard!